MX2019000312A - Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico. - Google Patents

Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.

Info

Publication number
MX2019000312A
MX2019000312A MX2019000312A MX2019000312A MX2019000312A MX 2019000312 A MX2019000312 A MX 2019000312A MX 2019000312 A MX2019000312 A MX 2019000312A MX 2019000312 A MX2019000312 A MX 2019000312A MX 2019000312 A MX2019000312 A MX 2019000312A
Authority
MX
Mexico
Prior art keywords
pain
aceclofenac
betamethasone
post
treatment
Prior art date
Application number
MX2019000312A
Other languages
English (en)
Inventor
Del Carmen García Armenta Patricia
Alonso Chavez García José
Original Assignee
Federico Amezcua Amezcua
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Federico Amezcua Amezcua filed Critical Federico Amezcua Amezcua
Priority to MX2019000312A priority Critical patent/MX2019000312A/es
Publication of MX2019000312A publication Critical patent/MX2019000312A/es
Priority to US17/421,474 priority patent/US20220062300A1/en
Priority to PCT/MX2019/000139 priority patent/WO2020145811A1/es
Priority to EP19908967.3A priority patent/EP3909574A4/en
Priority to CA3126226A priority patent/CA3126226A1/en
Priority to CONC2021/0010388A priority patent/CO2021010388A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Abstract

La presente invención está relacionada con una composición farmacéutica compuesta por la combinación sinérgica de un analgésico antiinflamatorio no esteroideo como lo es el Aceclofenaco o sus sales farmacéuticamente aceptables y un agente antiinflamatorio esteroideo como lo es el principio activo Betametasona o sus sales farmacéuticamente aceptables de fosfato o dipropionato, los cuales se encuentran formulados para ser administrado por vía inyectable intramuscular o intravenosa misma que está indicada para el tratamiento del dolor en las formas localizas de afecciones reumáticas o en pacientes postquirúrgicos.
MX2019000312A 2019-01-08 2019-01-08 Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico. MX2019000312A (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
MX2019000312A MX2019000312A (es) 2019-01-08 2019-01-08 Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.
US17/421,474 US20220062300A1 (en) 2019-01-08 2019-12-16 Synergic pharmaceutical composition of aceclofenac and betamethasone for treating the pain of rheumatic conditions or postsurgical pain
PCT/MX2019/000139 WO2020145811A1 (es) 2019-01-08 2019-12-16 Composición farmacéutica sinérgica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumáticas o dolor postquirúrgico
EP19908967.3A EP3909574A4 (en) 2019-01-08 2019-12-16 SYNERGISTIC PHARMACEUTICAL COMPOSITION OF ACECLOFENAC AND BETAMETHASONE FOR THE TREATMENT OF PAIN IN RHEUMATIC DISEASES OR POST-OPERATIVE PAIN
CA3126226A CA3126226A1 (en) 2019-01-08 2019-12-16 Aceclofenac and betamethasone synergic pharmaceutical composition for the treatment of pain caused by rheumatic diseases or post-surgical pain
CONC2021/0010388A CO2021010388A2 (es) 2019-01-08 2021-08-06 Composición farmacéutica sinérgica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumáticas o dolor postquirúrgico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2019000312A MX2019000312A (es) 2019-01-08 2019-01-08 Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.

Publications (1)

Publication Number Publication Date
MX2019000312A true MX2019000312A (es) 2019-10-09

Family

ID=69416577

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019000312A MX2019000312A (es) 2019-01-08 2019-01-08 Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.

Country Status (6)

Country Link
US (1) US20220062300A1 (es)
EP (1) EP3909574A4 (es)
CA (1) CA3126226A1 (es)
CO (1) CO2021010388A2 (es)
MX (1) MX2019000312A (es)
WO (1) WO2020145811A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3838270A4 (en) * 2018-08-13 2022-03-09 Amézcua Amézcua, Federico SYNERGISTIC PHARMACEUTICAL COMPOSITION WITH ACECLOFENAC AND BETAMETHASONE FOR THE TREATMENT OF PAIN IN LOCALIZED FORMS OF RHEUMATIC DISEASES

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053865A (en) 1958-03-19 1962-09-11 Merck & Co Inc Novel 16-alkyl and 16-alkylene steroids and processes
US3104246A (en) 1961-08-18 1963-09-17 Roussel Uclaf Process of preparation of beta-methasone
ES8404783A1 (es) 1983-03-21 1984-05-16 Prodes Sa Procedimiento para la obtencion del ester del acido 2-(2,6-diclorofenil)amino bencenoacetico con acido glicolico.
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
MXPA05010505A (es) * 2005-09-29 2007-03-28 Leopoldo Espinosa Abdala Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona.
WO2007072503A2 (en) * 2005-12-21 2007-06-28 Panacea Biotec Ltd. Combinations for managing inflammation and associated disorders
US8361492B2 (en) 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
US9597527B2 (en) 2010-07-17 2017-03-21 Merck Patent Gmbh Enhancement of penetration and action
MX348595B (es) * 2013-08-02 2017-06-21 Laboratorio Raam De Sahuayo S A De C V Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
US10143685B2 (en) * 2015-01-28 2018-12-04 David Berkheimer Parenteral and topical compositions for pain
WO2017205461A1 (en) * 2016-05-27 2017-11-30 Goldbrecht Inc. Adjustable header for sliding doors and windows
RU2017123274A (ru) * 2017-06-30 2019-01-09 Общество с ограниченной ответственностью "ФБК" Комбинированное средство на основе нпвс, глюкокортикостероида и витамина
RU2017123271A (ru) * 2017-06-30 2019-01-09 Общество с ограниченной ответственностью "ФБК" Комбинированное средство на основе нпвс и глюкокортикостероида
EP3838270A4 (en) * 2018-08-13 2022-03-09 Amézcua Amézcua, Federico SYNERGISTIC PHARMACEUTICAL COMPOSITION WITH ACECLOFENAC AND BETAMETHASONE FOR THE TREATMENT OF PAIN IN LOCALIZED FORMS OF RHEUMATIC DISEASES

Also Published As

Publication number Publication date
CA3126226A1 (en) 2020-07-16
US20220062300A1 (en) 2022-03-03
CO2021010388A2 (es) 2021-08-30
EP3909574A4 (en) 2022-03-09
WO2020145811A1 (es) 2020-07-16
EP3909574A1 (en) 2021-11-17

Similar Documents

Publication Publication Date Title
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
BR112015029401A2 (pt) derivados pirazolo-pirrolidin-4-ona e seu uso no tratamento de doenças
EA201491479A1 (ru) Производные лупановых тритерпеноидов и их фармацевтическое применение
AR085662A1 (es) Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia
PE20091672A1 (es) Nueva dosificacion y formulacion
MX2021009199A (es) Conjugado de farmaco de dos ligandos y uso del mismo.
BR112015019369A2 (pt) derivados de ácido bisfenil butanóico substituídos como inibidores de nep (endopeptidase neutra)
MX2018013715A (es) Composiciones acuosas de capsaicinoides que comprenden un analgesico y un vehiculo acuoso, y uso de las mismas para el tratamiento del dolor.
MX2016006179A (es) Formulaciones de capsaicinoides basadas en agua y metodos de manufactura y uso.
BR112015031846A2 (pt) derivados de estratrientiazol substituído por 17-nitrogênio terapeuticamente ativos como inibidores de 17.beta-hidroxiesteroide desidrogenase
CY1123695T1 (el) Φαρμακευτικη συνθεση με αντιφλεγμονωδεις παραγοντες και διαδικασια παρασκευης
CO6220945A2 (es) Uso de una composicion que comprende formoterol y dipropianato de beclometasona para la prevencion y/o tratamiento de una exacerbacion de asma
BR112019007863A2 (pt) derivados de naftiridinona inovadores e seu uso no tratamento de arritmia
BR112015014292A2 (pt) compostos tricíclicos para inibição do canal de cftr
MX2019000312A (es) Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.
WO2020036478A3 (es) Composición farmacéutica sinérgica de aceclofenaco y betametasona para el tratamiento del dolor en las formas localizadas de afecciones reumáticas
MX2013001279A (es) Composicion farmaceutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral.
RU2013105513A (ru) Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи
BR112015019307A2 (pt) derivados de ácido butanoico substituído com bisfenila como inibidores de nep com eficácia in vivo melhorada
MX2018005298A (es) Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa.
TN2016000179A1 (en) Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor.
MX2018011142A (es) Combinacion farmaceutica sinergica de un inhibidor selectivo de la ciclooxigenasa 2 y un derivado de antraquinona.
BINDRA et al. Dexamethasone Induced Perineal Pruritus in Patients Undergoing Minor Oral Surgical Procedures-A Prospective Cohort Study.
CO2021006473A2 (es) Composición farmacéutica que comprende la combinación de un inhibidor selectivo de la ciclooxigenasa 2 y un carbamato derivado de la guaifenesina para el tratamiento del dolor, inflamación y contractura muscular
AR118056A2 (es) Formulaciones de inhibidor de histona desacetilasa en combinación con bendamustina y uso de las mismas